144 results on '"Marcacci G"'
Search Results
2. Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
3. Affective temperament in the eating disorders
4. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
5. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
6. Single dose palonosetron (0.25 mg) for the prevention of acute and delayed nausea and vomiting in patients undergoing HDCT and stem cell transplantation
7. Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkinʼs lymphoma: results of a pilot study
8. Balloon occlusion of the carotid artery in the treatment of cavernous giant aneurysms: two cases
9. Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report
10. Elsberg syndrome: radiculomyelopathy and acute urinary retention in patient with genital herpes
11. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia after Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
12. RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma
13. Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
14. Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma
15. Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: Two case reports
16. Parkinsonian syndrome in the course of aqueductal stenosis hydrocephalus
17. 'Augmentation with cognitive-behavioral therapy in panic disorder patients with partial response to pharmacotherapy', Treatments in psychiatry: a new update World psychiatric Association International Congress
18. Caratteristiche psicopatologiche in pazienti con Bulimia Nervosa Purging Type, Bulimia Nervosa Nonpurging Type e Binge eating Disorder
19. Cognitive-behavior therapy, in patients with panic disorder presenting partial response to pharmacotherapy
20. Trattamento ambulatoriale del BED: verifica di un nuovo approccio
21. Personalità: differenze tra bulimiche con o senza condotte di eleiminazione e BED
22. Trattamento ambulatoriale del Binge Eating Disorder: verifica di un nuovo approccio
23. Differenze psicopatologiche in tre gruppi diagnostici: Bulimiche con e senza condotte di eliminazione e BED
24. Different pathways towards Anorexia Nervosa
25. Personalità e temperamento: differenze fra Bulimiche con e senza Condotte di Eliminazione e BED
26. Spettro affettivo ed ossessivo-compulsivo in sottogruppi di DCA
27. Consumo di caffeina nei pazienti con Disturbo della Condotta Alimentare (differenze nei sottogruppi)
28. Problems of treatment in the neurological complications of Vaquez disease
29. psicoterapie brevi. Quanto brevi? Psicoterapia della bulimia nervosa
30. 'Binge Eating Disorder and Subclinical Eating Disorder manifestations in sample of Bipolar I outpatients.'
31. 'Silent pericardial effusion in a sample of anorexic patients'
32. A phase II study of R-COMP14 in elderly patients with high-risk diffuse large B-cell lymphoma (DLBCL) and moderate to high “life threat” impact cardiopathy.
33. Single Vs Double Dose Palonosetron For The Prevention Of Acute And Delayed Nausea And Vomiting In Patients Undergoing High Dose Chemotherapy And Autologous Stem Cell Transplantation
34. Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
35. 9249 Single vs double dose palonosetron for the prevention of acute and delayed nausea and vomiting in patients undergoing high dose chemotherapy and autologous stem cell transplantation
36. Rituximab plus gemcitabine, ifosfamide, oxaliplatin (R-GIFOX) as salvage therapy for recurrent Hodgkin lymphoma
37. 97: Positron Emission Tomography Identifies a Differential Pattern of Bone Marrow FdG Uptake in “Poor” and “Good” Peripheral Stem Cell Mobilizers
38. Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin’s lymphoma: Results of a pilot study
39. Anticholinesterase treatment modulates cytokine network in Alzheimer's disease
40. Substance abuse and axis I comorbidity in psychotic disorders
41. Characteristics of mixed and pure mania in bipolar disorder with psychotic features
42. MOPP/EBVD +/− local RT for advanced Hodgkin's disease
43. Axis I comorbidity in bipolar disorder with psychotic features.
44. Comparison of fixed dose (6 mg) pegfilgrastim and daily filgrastim to accelerate hemopoietic recovery after autologous stem cell transplantation (ASCT)
45. Headache, seizures and repente strokes in a young subject: a new case of MELAS-like syndrome?
46. Fotemustine, etoposide, cytosine arabinoside and melphalan (FEAM): A new conditioning regimen for the hematopoietic stem cell autotransplant in patients with lymphoma,Fotemustine, etoposide, citosina-arabinoside e melphalan (FEAM), un nuovo regime di condizionamento per autotrapianto di cellule staminali in pazienti affetti da linfoma
47. [Mitochondrial oculopharyngeal myopathy: description of a case]
48. Corticospinal tract degeneration in motor neuron disease
49. The costs of multiple sclerosis: A cross-sectional, multicenter cost-of-illness study in Italy
50. Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.